Header Logo

Connection

ANITA SABICHI to Male

Back to Details
This is a "connection" page, showing publications ANITA SABICHI has written about Male.
ANITA SABICHI
Connection Strength
0.163
Male
  1. Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder. J Immunother. 2017 04; 40(3):114-116.
    View in: PubMed
    Score: 0.023
  2. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila). 2011 Oct; 4(10):1580-9.
    View in: PubMed
    Score: 0.016
  3. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9.
    View in: PubMed
    Score: 0.012
  4. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84.
    View in: PubMed
    Score: 0.011
  5. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1704-9.
    View in: PubMed
    Score: 0.010
  6. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):36-44.
    View in: PubMed
    Score: 0.009
  7. COX-2 inhibitors and other NSAIDs in bladder and prostate cancer. Prog Exp Tumor Res. 2003; 37:163-78.
    View in: PubMed
    Score: 0.009
  8. Primary Spinal Cord Melanoma - An Uncommon Entity. Can J Neurol Sci. 2019 05; 46(3):348-350.
    View in: PubMed
    Score: 0.007
  9. Nivolumab Treatment for Cancers in the HIV-infected Population. J Immunother. 2018 Oct; 41(8):379-383.
    View in: PubMed
    Score: 0.006
  10. Regulation of nuclear oncogenes expressed in lung cancer cell lines. J Cell Biochem Suppl. 1996; 24:218-27.
    View in: PubMed
    Score: 0.005
  11. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer. Mol Cancer Res. 2015 May; 13(5):809-18.
    View in: PubMed
    Score: 0.005
  12. The molecular biology of lung cancer: application to early detection and prevention. Oncology (Williston Park). 1993 Jun; 7(6):19-26; discussion 31-2, 37.
    View in: PubMed
    Score: 0.004
  13. Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. Arch Ophthalmol. 2012 Dec; 130(12):1608-11.
    View in: PubMed
    Score: 0.004
  14. Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization. Head Neck. 2010 Aug; 32(8):1118-24.
    View in: PubMed
    Score: 0.004
  15. Mortality in the randomized, controlled lung intergroup trial of isotretinoin. Cancer Prev Res (Phila). 2010 Jun; 3(6):738-44.
    View in: PubMed
    Score: 0.004
  16. High-dose fenretinide in oral leukoplakia. Cancer Prev Res (Phila). 2009 Jan; 2(1):22-6.
    View in: PubMed
    Score: 0.003
  17. Clinical model of cost of bladder cancer in the elderly. Urology. 2008 Mar; 71(3):519-25.
    View in: PubMed
    Score: 0.003
  18. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol. 2007 May 20; 25(15):1974-8.
    View in: PubMed
    Score: 0.003
  19. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology. 2006 Sep; 68(3):549-53.
    View in: PubMed
    Score: 0.003
  20. Comparative outcomes of bladder cancer. Obstet Gynecol. 2006 Jul; 108(1):169-75.
    View in: PubMed
    Score: 0.003
  21. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma. Oncogene. 2006 Sep 28; 25(44):6015-25.
    View in: PubMed
    Score: 0.003
  22. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res. 2005 Jul 15; 65(14):6189-98.
    View in: PubMed
    Score: 0.003
  23. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1697-702.
    View in: PubMed
    Score: 0.003
  24. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia. 2005 Mar; 7(3):280-93.
    View in: PubMed
    Score: 0.002
  25. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1710-6.
    View in: PubMed
    Score: 0.002
  26. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem. 2004 Apr 30; 279(18):19191-200.
    View in: PubMed
    Score: 0.002
  27. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003 Oct; 76(4):1001-7; discussion 1007-8.
    View in: PubMed
    Score: 0.002
  28. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res. 2001 Mar 15; 61(6):2720-6.
    View in: PubMed
    Score: 0.002
  29. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev. 2000 Nov; 9(11):1171-82.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.